Short and Long Term Prognosis of Patients Admitted to the ED With Acute Heart Failure (CRF)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03806972 |
Recruitment Status :
Completed
First Posted : January 16, 2019
Last Update Posted : October 13, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Heart failure (HF) is the leading cause of hospitalization ,rehospitalization and mortality for adults over 65 years of age.
This study aimed to assess mortality, and hospitalization rates at 30 days and one year after dicharge of patients with heart failure (HF) with reduced ejection fraction (HFrEF) compared to HF with preserved ejection fraction (HFpEF).
Condition or disease |
---|
Acute Heart Failure |
Study Type : | Observational [Patient Registry] |
Actual Enrollment : | 1800 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 12 Months |
Official Title: | Short and Long Term Prognosis of Patients Admitted to the Emergency Department With Acute Heart Failure |
Actual Study Start Date : | June 1, 2009 |
Actual Primary Completion Date : | October 1, 2021 |
Actual Study Completion Date : | October 1, 2021 |

- Death or readmission rates [ Time Frame: within 365 days after hospital discharge ]A composite outcome of Death or readmission within 365 days of hospital discharge
- Death or readmission rates [ Time Frame: within 30 days after hospital discharge ]A composite outcome of Death or readmission within 30 days of hospital discharge

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- patients admitted to the ED of Monastir with a principal discharge diagnosis code for HF.
Exclusion Criteria:
- Pregnant or breast feeding women. Alteration of consciousness GCS < 15 Critically ill patients needing immediate mechanical hemodynamic of ventilatory support.
Inability to follow instructions or comply with follow-up procedures.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03806972
Tunisia | |
Emergency Departement | |
Monastir, Tunisia, 5000 |
Principal Investigator: | Nouira Semir, Professor | university Hospital of Monastir |
Publications:
Responsible Party: | Pr. Semir Nouira, professor, University of Monastir |
ClinicalTrials.gov Identifier: | NCT03806972 |
Other Study ID Numbers: |
CRF |
First Posted: | January 16, 2019 Key Record Dates |
Last Update Posted: | October 13, 2021 |
Last Verified: | October 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
acute heart failure prognosis |
Heart Failure Heart Diseases Cardiovascular Diseases |